{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:12:29Z","timestamp":1791997949286,"version":"4.4.0"},"reference-count":88,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cardiovascular disease and cancer remain the leading causes of hospitalization and mortality in high-income countries. Survival after myocardial infarction has improved but there is still a difference in clinical outcome, mortality, and developing heart failure to the disadvantage of women with myocardial infarction. Most major cardiology trials and registries have excluded patients with cancer. As a result, there is only very limited information on the effects of coronary artery disease in cancer patients. In particular, the outcomes in women with cancer and coronary artery disease and its management remain empiric. We reviewed studies of over 27 million patients with coronary artery disease and cancer. Our review focused on the most important types of cancer (breast, colon, lung, prostate) and hematological malignancies with particular attention to sex-specific differences in treatment and prognosis.<\/jats:p>","DOI":"10.3390\/cancers14020434","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T20:44:00Z","timestamp":1642365840000},"page":"434","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Coronary Artery Disease and Cancer: Treatment and Prognosis Regarding Gender Differences"],"prefix":"10.3390","volume":"14","author":[{"given":"Stefan A.","family":"Lange","sequence":"first","affiliation":[{"name":"Department of Cardiology I\u2014Coronary and Peripheral Vascular Disease, Heart Failure, Cardiol, University Hospital Muenster, D-48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Reinecke","sequence":"additional","affiliation":[{"name":"Department of Cardiology I\u2014Coronary and Peripheral Vascular Disease, Heart Failure, Cardiol, University Hospital Muenster, D-48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/heartjnl-2014-307310","article-title":"Acute Myocardial Infarction Trends in Europe (AMITIE) Study Investigators. Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations","volume":"101","author":"Salomaa","year":"2015","journal-title":"Heart"},{"key":"ref_2","unstructured":"(2021, August 01). International Agency for Research on Cancer. Available online: https:\/\/www.iarc.who.int\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e014383","DOI":"10.1161\/JAHA.119.014383","article-title":"Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients with First Myocardial Infarction: A Nationwide Study","volume":"9","author":"Velders","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared Risk Factors in Cardiovascular Disease and Cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehy004","article-title":"Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: Results from the German prospective, multicentre FITT-STEMI trial","volume":"39","author":"Scholz","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/eurheartj\/ehy769","article-title":"Percutaneous coronary intervention in cancer patients: A report of the prevalence and outcomes in the United States","volume":"40","author":"Potts","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/CIRCULATIONAHA.120.048015","article-title":"Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure?","volume":"142","author":"Ezekowitz","year":"2020","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/clc.23662","article-title":"Gender differences in acute myocardial infarction\u2014A nationwide German real-life analysis from 2014 to 2017","volume":"44","author":"Kuehnemund","year":"2021","journal-title":"Clin. Cardiol."},{"key":"ref_10","unstructured":"European Union (2020, August 10). ECIS\u2014European Cancer Information System. Available online: https:\/\/ecis.jrc.ec.europa.eu."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/2048872617729636","article-title":"Treatment of patients with myocardial infarction depends on history of cancer","volume":"7","author":"Rohrmann","year":"2018","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00432-015-2056-5","article-title":"Analysis of outcomes of percutaneous coronary intervention in metastatic cancer patients with acute coronary syndrome over a 10-year period","volume":"142","author":"Guddati","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2018.10.008","article-title":"Acute coronary syndromes in patients with active hematologic malignancie\u2014Incidence, management, and outcomes","volume":"275","author":"Park","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e13476","DOI":"10.1111\/ijcp.13476","article-title":"Management strategies and clinical outcomes of acute myocardial infarction in leukaemia patients: Na-tionwide insights from United States hospitalisations","volume":"74","author":"Mohamed","year":"2020","journal-title":"Int. J. Clin. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00380-021-01817-y","article-title":"Temporal trends in short and long-term outcomes after percutaneous coronary interventions among cancer patients","volume":"36","author":"Agmon","year":"2021","journal-title":"Heart Vessel."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.ijcard.2012.11.009","article-title":"Comparison of treatment and outcome of acute myocardial infarction between cancer patients and non-cancer patients","volume":"167","author":"Kurisu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.amjcard.2012.10.007","article-title":"Influence of Gender on Ischemic Times and Outcomes After ST-Elevation Myocardial Infarction","volume":"111","author":"Velders","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.mayocp.2016.06.029","article-title":"Cancer History Portends Worse Acute and Long-term Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Inter-vention for Acute ST-Segment Elevation Myocardial Infarction","volume":"91","author":"Wang","year":"2016","journal-title":"Mayo. Clin. Proc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MCA.0000000000000429","article-title":"Long-term outcomes after percutaneous coronary interventions in cancer survivors","volume":"28","author":"Landes","year":"2017","journal-title":"Coron. Artery Dis."},{"key":"ref_20","first-page":"200","article-title":"Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an Obser-vation from Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2). CREDO-Kyoto PCI\/CABG Registry Cohort-2 Investigators","volume":"4","author":"Nakatsuma","year":"2018","journal-title":"Eur. Heart J.-Qual. Care Clin. Outcomes"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/2048872617706501","article-title":"Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: A BleeMACS substudy","volume":"7","author":"Iannaccone","year":"2018","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_22","first-page":"e9071","article-title":"In-Hospital Mortality Risk in Post-Percutaneous Coronary Inter-ventions Cancer Patients: A Nationwide Analysis of 1.1 Million Heart Disease Patients","volume":"12","author":"Gaddam","year":"2020","journal-title":"Cureus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurheartj\/ehaa1032","article-title":"Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA","volume":"42","author":"Kwok","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1536\/ihj.20-452","article-title":"The Effect of a Cancer History on Patients with Acute Myocardial Infarction After Percutaneous Coronary Intervention","volume":"62","author":"Takeuchi","year":"2021","journal-title":"Int. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.21037\/atm.2017.11.29","article-title":"Temporal trends and outcomes of acute myocardial infarction in patients with cancer","volume":"5","author":"Pothineni","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/cncr.31174","article-title":"Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013","volume":"124","author":"Gong","year":"2018","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.acvd.2019.06.012","article-title":"In-hospital outcomes and 5-year mortality following an acute myocardial infarction in patients with a history of cancer: Results from the French registry on Acute ST-elevation or non-ST-elevation myocardial infarction (FAST-MI) 2005 cohort","volume":"112","author":"Ederhy","year":"2019","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/eurheartj\/ehz851","article-title":"Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA","volume":"41","author":"Bharadwaj","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: A population-based cohortstudy using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2011.09.015","article-title":"Risk of coronary heart disease in patients with cancer: A nationwide follow-up study from Sweden","volume":"48","author":"Ji","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"001779","DOI":"10.1161\/JAHA.115.001779","article-title":"Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention","volume":"4","author":"Hess","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.amjcard.2013.08.019","article-title":"Outcome After ST Elevation Myocardial Infarction in Patients With Cancer Treated With Primary Percutaneous Coronary Intervention","volume":"112","author":"Velders","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10741-019-09808-y","article-title":"Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: A nationwide population-based study","volume":"24","author":"Ram","year":"2019","journal-title":"Heart Fail. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/S0140-6736(21)00684-X","article-title":"The Lancet women and cardiovascular disease Commission: Reducing the global burden by 2030","volume":"397","author":"Vogel","year":"2021","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ehjqcco\/qcz040","article-title":"Healthcare disparities for women hospitalized with myocardial infarction and angina","volume":"6","author":"Jackson","year":"2020","journal-title":"Eur. Heart J.-Qual. Care Clin. Outcomes"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jacc.2016.06.027","article-title":"Takotsubo Stress Cardiomyopathy: \u201cGood News\u201c in Cancer Patients?","volume":"68","author":"Munoz","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/jamainternmed.2014.4762","article-title":"Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: A meta-analysis","volume":"174","author":"Pancholy","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-1013679","article-title":"Coronary Artery and Aortic Valve Disease as a Long-Term Sequel of Mediastinal and Thoracic Irradiation","volume":"45","author":"Kleikamp","year":"1997","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jamaoncol.2019.2803","article-title":"Overall Mortality After Diagnosis of Breast Cancer in Men vs Women","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1080\/03007995.2017.1322052","article-title":"Causes of death in long-term lung cancer survivors: A SEER database analysis","volume":"33","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Radmilovic, J., Di Vilio, A., D\u2019Andrea, A., Pastore, F., Forni, A., Desiderio, A., Ragni, M., Quaranta, G., Cimmino, G., and Russo, V. (2020). The Pharmacological Approach to Oncologic Patients with Acute Coronary Syndrome. J. Clin. Med., 9.","DOI":"10.3390\/jcm9123926"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2019.07.079","article-title":"Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week","volume":"74","author":"Ball","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"H164","DOI":"10.1152\/ajpheart.00277.2019","article-title":"Cancer therapy-induced cardiovascular toxicity: Old\/new problems and old drugs","volume":"317","author":"Beyer","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2353\/ajpath.2006.050409","article-title":"Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-\/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage","volume":"168","author":"Stewart","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.amjcard.2013.07.031","article-title":"Cardiovascular Complications of Radiotherapy","volume":"112","author":"Lee","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaccao.2021.06.007","article-title":"Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification","volume":"3","author":"Bergom","year":"2021","journal-title":"JACC CardioOncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-5223(19)38881-6","article-title":"Coronary artery disease following mediastinal radiation therapy","volume":"85","author":"Annest","year":"1983","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/annonc\/mdz414","article-title":"Gender medicine and oncology: Report and consensus of an ESMO workshop","volume":"30","author":"Wagner","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jama.2009.1137","article-title":"Hormonal Therapy Use for Prostate Cancer and Mortality in Men With Coronary Artery Disease\u2013Induced Congestive Heart Failure or Myocardial Infarction","volume":"302","author":"Nanda","year":"2009","journal-title":"JAMA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/bju.12905","article-title":"Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer","volume":"116","author":"Ziehr","year":"2015","journal-title":"BJU Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa1815671","article-title":"ARAMIS Investigators. Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer","volume":"380","author":"Fizazi","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1016\/j.clgc.2019.07.001","article-title":"New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes","volume":"17","author":"Mollica","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.urolonc.2020.08.003","article-title":"Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer","volume":"39","author":"Morgans","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1161\/ATVBAHA.119.313046","article-title":"Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses","volume":"40","author":"Hu","year":"2020","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/CAD.0b013e3283100e9c","article-title":"Cisplatin-associated thrombosis","volume":"19","author":"Jafri","year":"2008","journal-title":"Anti-Cancer Drugs"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","article-title":"Cardiotoxicity in cancer patients treated with 5-fluorouracil or cape-citabine: A systematic review of incidence, manifestations and predisposing factors","volume":"39","author":"Polk","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/djr242","article-title":"Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis","volume":"103","author":"Amir","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00280-012-2018-4","article-title":"Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: Results from a prospective population pharmacokinetic study","volume":"71","author":"Mueller","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/annonc\/mdw673","article-title":"Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: A systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Filion","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"006278","DOI":"10.1161\/JAHA.117.006278","article-title":"Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis of More Than 20 000 Patients","volume":"6","author":"Totzeck","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Brown, L.J., Meredith, T., Yu, J., Patel, A., Neal, B., Arnott, C., and Lim, E. (2021). Heart Failure Therapies for the Prevention of HER2-Monoclonal Antibody-Mediated Cardiotoxicity: A Systematic Review and Meta-Analysis of Randomized Trials. Cancers, 13.","DOI":"10.3390\/cancers13215527"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1007\/s00520-016-3310-3","article-title":"Epidemiology Section of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer, 2013. Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents","volume":"24","author":"Escalante","year":"2016","journal-title":"Support. Care Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S1470-2045(14)70486-3","article-title":"Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: A pooled analysis of individual patient data from four randomised controlled trials","volume":"15","author":"Schmoll","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000480661","article-title":"Oxaliplatin-Induced Acute ST Segment Elevation Mimicking Myocardial Infarction: A Case Report","volume":"41","author":"Weidner","year":"2018","journal-title":"Oncol. Res. Treat."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e1956","DOI":"10.1634\/theoncologist.2020-0225","article-title":"Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Func-tion, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer","volume":"25","author":"Groehs","year":"2020","journal-title":"Oncologist"},{"key":"ref_67","first-page":"002140","article-title":"Concurrent chemoradiotherapy in non-small cell lung cancer","volume":"6","author":"Figuls","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tox.2016.10.001","article-title":"An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures","volume":"371","author":"Dugbartey","year":"2016","journal-title":"Toxicology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4103\/0973-1482.103530","article-title":"Acute non-ST elevation myocardial infarction following paclitaxel administration for ovarian carcinoma: A case report and review of literature","volume":"8","author":"Shah","year":"2012","journal-title":"J. Cancer Res. Ther."},{"key":"ref_70","first-page":"748","article-title":"Non-Q-wave myocardial infarction associated with bleomycin and etoposide chemotherapy","volume":"12","author":"Schwarzer","year":"1991","journal-title":"Eur. Heart J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1179\/1973947814Y.0000000232","article-title":"Acute ischaemic stroke and myocardial infarction after chemotherapy with vinorelbine for non-small cell lung cancer: A case report","volume":"29","author":"Zerna","year":"2017","journal-title":"J. Chemother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/JCO.1995.13.2.531","article-title":"Myocardial ischemia and infarction associated with vinorelbine","volume":"13","author":"Bergeron","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/0959-8049(96)00141-4","article-title":"Myocardial infarction associated with vinorelbine (Navelbine)","volume":"32","author":"Zabernigg","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3816\/CLM.2006.n.039","article-title":"Phase II evaluation of gemcitabine mono-therapy for cutaneous T-cell lymphoma","volume":"7","author":"Duvic","year":"2006","journal-title":"Clin. Lymphoma Myeloma"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/000331979905001208","article-title":"Acute myocardial infarction following gemcitabine therapy\u2014A case report","volume":"50","author":"Kalapura","year":"1999","journal-title":"Angiology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"bcr2014208203","DOI":"10.1136\/bcr-2014-208203","article-title":"Rituximab-induced Takotsubo syndrome: More cardiotoxic than it appears?","volume":"2015","author":"Ng","year":"2015","journal-title":"BMJ Case Rep."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Varga, A., Tilea, I., Petra, D.N., Tilinca, M.-C., Gliga, M.L., and Demian, S. (2020). Cardiovascular Events throughout the Disease Course in Chronic Myeloid Leukaemia Patients Treated with Tyrosine Kinase Inhibitors\u2014A Single-Centre Retrospective Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103269"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/bloodadvances.2019001329","article-title":"First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: A systematic review and meta-analysis","volume":"4","author":"Vener","year":"2020","journal-title":"Blood Adv."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/ehf2.13365","article-title":"Adjuvant breast cancer treatments car-diotoxicity and modern methods of detection and prevention of cardiac complications","volume":"8","author":"Bikiewicz","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11886-012-0287-5","article-title":"Radial versus femoral access for percutaneous coronary intervention: Implications for vascular com-plications and bleeding","volume":"14","author":"Nathan","year":"2012","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.1002\/ccd.26379","article-title":"SCAI Expert consensus statement: Evaluation, management, and special considerations of car-dio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiolog\u0131a intervencionista)","volume":"87","author":"Iliescu","year":"2016","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"LEADERS FREE Investigators.Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk","volume":"373","author":"Urban","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1910021","article-title":"ONYX ONE Investigators. Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk","volume":"382","author":"Windecker","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ehjcvp\/pvaa127","article-title":"Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug eluting stent im-plantation: A network Meta-analysis","volume":"8","author":"Benenati","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"9934535","DOI":"10.1155\/2021\/9934535","article-title":"Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis","volume":"2021","author":"Xu","year":"2021","journal-title":"J. Interv. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without Aspirin in High-Risk Patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e003469","DOI":"10.1161\/CIRCINTERVENTIONS.115.003469","article-title":"A. Evaluation of early healing profile and neointimal transformation over 24 months using longitudinal sequential optical coherence tomography assessments and 3-year clinical results of the new dual-therapy endothelial progenitor cell capturing sirolimus-eluting combo stent: The EGO-Combo study","volume":"9","author":"Lee","year":"2016","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e004801","DOI":"10.1161\/CIRCINTERVENTIONS.116.004801","article-title":"Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging: The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent with Biodegradable Polymer at 1, 2, and 3 Months)","volume":"10","author":"Chevalier","year":"2017","journal-title":"Circ. Cardiovasc. Interv."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/2\/434\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:27:31Z","timestamp":1760362051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/2\/434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,16]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["cancers14020434"],"URL":"https:\/\/doi.org\/10.3390\/cancers14020434","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,16]]}}}